ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 13

Prevalence of Celiac Antibodies and IgA deficiency in Juvenile Idiopathic Arthritis

Angela Taneja1, Sampath Prahalad2, Aimee O. Hersh3, Lori Ponder4, Lai Hin Kimi Chan5, Kelly A. Rouster-Stevens6, Anne E Tebo7, Subramanian Kugathasan8 and John F. Bohnsack9, 1Pediatric Rheumatology, Emory University School of Medicine, Atlanta, GA, 2Pediatrics, Emory Children's Center, Atlanta, GA, 3Pediatrics/Rheumatology, University of Utah, Salt Lake City, UT, 4Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, GA, 5Pediatrics, Emory University School of Medicine, Atlanta, GA, 6Pediatric Rheumatology, Emory Children's Center, Atlanta, GA, 7University of Utah, Salt Lake City, UT, 8Gastroenterology, Emory University School of Medicine, Atlanta, GA, 9Division of Allergy, Immunology and Pediatric Rheumatology, University of Utah, Salt Lake City, UT

Meeting: 2017 Pediatric Rheumatology Symposium

Keywords: juvenile idiopathic arthritis (JIA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Thursday, May 18, 2017

Title: Clinical and Therapeutic Poster Breakout I

Session Type: Abstract Submissions

Session Time: 4:45PM-5:15PM

 

Background/Purpose: Juvenile Idiopathic Arthritis (JIA) is the most common chronic arthritis of childhood. The prevalence of autoimmunity is higher in JIA cases and relatives. The prevalence of celiac disease (CD) in JIA has been reported to be 0.1% to 7% in small studies. CD is 3 to 10-fold higher in asymptomatic individuals with other autoimmune diseases or chromosomal abnormalities for which screening is recommended. Tissue transglutaminase (tTG) IgA has high specificity for CD in individuals with normal IgA levels. The prevalence of IgA deficiency ranges between 1 in 330 to 2200 persons, and has been reported to be higher in JIA. Our aims were to estimate the prevalence of IgA deficiency and tTG IgA in a cohort of JIA followed in two large academic medical centers.

Methods: Subjects were 830 cases with JIA per the ILAR criteria (ages 3 to 21 at the time of collection) and 205 healthy controls (ages 3 to 69). Serum was collected and stored from all subjects and analyzed in a reference laboratory for total IgA (Quantitative Nephelometry) and tTG IgA antibody levels (Semi-Quantitative Enzyme-Linked Immunosorbent Assay). Standard reference levels of tTG IgA 0-3 U/mL as negative, 4-10 U/mL as weak positive and >10 U/mL as positive; and IgA <7 mg/dl for IgA deficiency were applied. Those with IgA deficiency were excluded from the tTG IgA analysis. Fisher’s exact tests were performed for statistical significance.

Results: Ten JIA cases (1.2%) and none of the controls had IgA deficiency (p = ns). Cases with IgA deficiency were mostly female (70%), and had the following JIA subtypes: oligoarticular = 5, polyarticular Rheumatoid Factor (RF)-negative = 2, polyarticular RF-positive = 2, and enthesitis-related = 1. In all 16 cases (2%), and 8 controls (3.9%) had an abnormal tTG (p =ns). After excluding the weak positives, we observed 7 cases (0.8%) and 3 controls (1.5%) with tTG IgA >10u/mL (p=ns). Cases with tTG IgA >10 u/mL were mostly female (71%), and were oligoarticular =3, polyarticular RF-negative =1, polyarticular RF-positive = 2 and enthesitis-related =1. From the healthy group with tTG IgA >10 u/mL the majority were female (67%).

Conclusion: Using the largest JIA cohort to date to investigate prevalence of celiac antibodies, we show that the prevalence of positive tTG IgA was 0.8% and the prevalence of IgA deficiency was 1.2%. Our results did not demonstrate a higher prevalence of abnormal tTG IgA in JIA. We do not recommend routine screening of asymptomatic JIA patients for CD.


Disclosure: A. Taneja, None; S. Prahalad, None; A. O. Hersh, None; L. Ponder, None; L. H. K. Chan, None; K. A. Rouster-Stevens, None; A. E. Tebo, None; S. Kugathasan, None; J. F. Bohnsack, 5.

To cite this abstract in AMA style:

Taneja A, Prahalad S, Hersh AO, Ponder L, Chan LHK, Rouster-Stevens KA, Tebo AE, Kugathasan S, Bohnsack JF. Prevalence of Celiac Antibodies and IgA deficiency in Juvenile Idiopathic Arthritis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 4). https://acrabstracts.org/abstract/prevalence-of-celiac-antibodies-and-iga-deficiency-in-juvenile-idiopathic-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/prevalence-of-celiac-antibodies-and-iga-deficiency-in-juvenile-idiopathic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology